AVS-1357 inhibits melanogenesis via prolonged ERK activation

Pharmazie

Volumn 64, Issue 8, 2009, Pages 532-537

  Kim, Dong Seok ^a   Lee, Hyun Kyung ^b   Park, Seo Hyoung ^b   Chae, Chong Hak ^c   Park, Kyoung Chan ^b  

^a Chung Ang University   (South Korea)

^b Seoul National University   (South Korea)

^c Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; AVS 1357; IMIDAZOLE DERIVATIVE; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MONOPHENOL MONOOXYGENASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; AVS-1357; MELANIN; MITF PROTEIN, MOUSE; ONCOPROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; MELANOGENESIS; MOUSE; NONHUMAN; ANIMAL; BIOSYNTHESIS; CELL LINE; CELL SURVIVAL; GENETICS; MELANOCYTE; METABOLISM; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; IMIDAZOLES; MELANINS; MELANOCYTES; MICE; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; ONCOGENE PROTEIN V-AKT;

EID: 70349757516     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2009.9507     Document Type: Article

References (35)

1. Ando H, Kondoh H, Ichihashi M, Hearing VJ (2007) Approaches to identify inhibitors of melanin biosynthesis via the quality control of tyrosinase. J Invest Dermatol 127: 751-761.
2. Bentley NJ, Eisen T, Goding CR (1994) Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol Cell Biol 14: 7996-8006.
3. Bertolotto C, Busca R, Abbe P, Bille K, Aberdam E, Ortonne JP et al. (1998) Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol Cell Biol 18: 694-702.
4. Briganti S, Camera E, Picardo M (2003) Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res 16: 101-110.
5. Busca R, Ballotti R (2000) Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res 13: 60-69.
6. Busca R, Bertolotto C, Ortonne JP, Ballotti R (1996) Inhibition of the phosphatidylinositol 3-kinase/p70(S6)-kinase pathway induces B16 melanoma cell differentiation. J Biol Chem 271: 31824-31830.
7. Chang TS (2007) Two potent suicide substrates of mushroom tyrosinase: 7,8,4′-trihydroxyisoflavone and 5,7,8,4′-tetrahydroxyisoflavone. Journal of agricultural and food chemistry 55: 2010-2015.
8. Cowley S, Paterson H, Kemp P, Marshall CJ (1994) Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77: 841-852.
9. Dooley TP, Gadwood RC, Kilgore K, Thomasco LM (1994) Development of an in vitro primary screen for skin depigmentation and antimelanoma agents. Skin Pharmacol 7: 188-200.
10. Englaro W, Bertolotto C, Busca R, Brunet A, Pages G, Ortonne JP et al. (1998) Inhibition of the mitogen-activated protein kinase pathway triggers B16 melanoma cell differentiation. J Biol Chem 273: 9966-9970.
11. Hearing VJ, Jimenez M (1989) Analysis of mammalian pigmentation at the molecular level. Pigment Cell Res 2: 75-85.
12. Hearing VJ, Tsukamoto K (1991) Enzymatic control of pigmentation in mammals. Faseb J 5: 2902-2909.
13. Hemesath TJ, Price ER, Takemoto C, Badalian T, Fisher DE (1998) MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature 391: 298-301.
14. Hughes AE, Newton VE, Liu XZ, Read AP (1994) A gene for Waardenburg syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12-p14.1. Nat Genet 7: 509-512.
15. Khaled M, Larribere L, Bille K, Aberdam E, Ortonne JP, Ballotti R, et al. (2002) Glycogen synthase kinase 3beta is activated by cAMP and plays an active role in the regulation of melanogenesis. J Biol Chem 277: 33690-33697.
16. Kim DS, Hwang ES, Lee JE, Kim SY, Kwon SB, Park KC (2003) Sphingosine-1-phosphate decreases melanin synthesis via sustained ERK activation and subsequent MITF degradation. J Cell Sci 116: 1699-1706.
17. Kim DS, Kim SY, Chung JH, Kim KH, Eun HC, Park KC (2002) Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes. Cell Signal 14: 779-785.
18. Kim DS, Park SH, Kwon SB, Park ES, Huh CH, Youn SW et al. (2006) Sphingosylphosphorylcholine-induced ERK activation inhibits melanin synthesis in human melanocytes. Pigment Cell Res 19: 146-153.
19. Kim DS, Park SH, Kwon SB, Youn SW, Park ES, Park KC (2005) Heat treatment decreases melanin synthesis via protein phosphatase 2A inactivation. Cell Signal 17: 1023-1031.
20. Kim DS, Park SH, Park KC (2004) Transforming growth factor-beta1 decreases melanin synthesis via delayed extracellular signal-regulated kinase activation. Int J Biochem Cell Biol 36: 1482-1491.
21. Kim YJ, Uyama H (2005) Tyrosinase inhibitors from natural and synthetic sources: structure, inhibition mechanism and perspective for the future. Cell Mol Life Sci 62: 1707-1723.
22. Koo HM, VanBrocklin M, McWilliams MJ, Leppla SH, Duesbery NS, Woude GF (2002) Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase. Proc Natl Acad Sci USA 99: 3052-3057.
23. Lin JY, Fisher DE (2007) Melanocyte biology and skin pigmentation. Nature 445: 843-850.
24. Marshall CJ (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185.
25. Oka M, Nagai H, Ando H, Fukunaga M, Matsumura M, Araki K et al. (2000) Regulation of melanogenesis through phosphatidylinositol 3-kinase-Akt pathway in human G361 melanoma cells. J Invest Dermatol 115: 699-703.
26. Park SH, Kim DS, Kim WG, Ryoo IJ, Lee DH, Huh CH et al. (2004) Terrein: a new melanogenesis inhibitor and its mechanism. Cell Mol Life Sci 61: 2878-2885.
27. Sale EM, Atkinson PG, Sale GJ (1995) Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis. Embo J 14: 674-684.
28. Slominski A, Tobin DJ, Shibahara S, Wortsman J (2004) Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 84: 1155-1228.
29. Tachibana M (1997) Evidence to suggest that expression of MITF induces melanocyte differentiation and haploinsufficiency of MITF causes Waardenburg syndrome type 2A. Pigment Cell Res 10: 25-33.
30. Tachibana M (2000) MITF: a stream flowing for pigment cells. Pigment Cell Res 13: 230-240.
31. Tassabehji M, Newton VE, Read AP (1994) Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet 8: 251-255.
32. Tsuboi T, Kondoh H, Hiratsuka J, Mishima Y (1998) Enhanced melanogenesis induced by tyrosinase gene-transfer increases boron-uptake and killing effect of boron neutron capture therapy for amelanotic melanoma. Pigment Cell Res 11: 275-282.
33. Wu M, Hemesath TJ, Takemoto CM, Horstmann MA, Wells AG, Price ER, et al. (2000) c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev 14: 301-312.
34. Xu W, Gong L, Haddad MM, Bischof O, Campisi J, Yeh ET, et al. (2000) Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. Exp Cell Res 255: 135-143.
35. Yasumoto K, Yokoyama K, Takahashi K, Tomita Y, Shibahara S (1997) Functional analysis of microphthalmia-associated transcription factor in pigment cell-specific transcription of the human tyrosinase family genes. J Biol Chem 272: 503-509.